Advanced searches left 3/3

Placebo - Crossref

Summarized by Plex Scholar
Last Updated: 26 September 2022

* If you want to update the article please login/register

Effects of Melatonin on Postoperative Delirium After PCI in Elderly Patients: A Randomized, Single-Center, Double-Blind, Placebo-Controlled Trial

Until now, experimental results have established the benefits of melatonin for the treatment of delirium. After a percutaneous transluminal coronary intervention in elderly patients, there were no conclutive conclusions regarding Mel on delirium. The present research found that intensive Mel therapy could reduce the incidence of delirium. Methods: Patients over the age of 60 were enrolled in intensive care units after PCI. Patients were randomly assigned Mel or placebo for up to seven days using a computer-generated randomization system. The incidence of postoperative delirium in the Mel group was noticeably lower than in the placebo group. Compared to those in the placebo group, the length of stay and hospitalization costs in the Mel group were dramatically reduced relative to those in the placebo group. Conclusion: Mel is safe and effective in the treatment of delirium following PCI, according to the latest report.

Source link: https://doi.org/10.1532/hsf.4049


Effects of Melatonin for Delirium in Elderly Acute Heart Failure Patients: A Randomized, Single-Center, Double-Blind, and Placebo-Controlled Trial

History: Delirium is a common, life-threatening disorder with the key clinical signs of temporary organic mental disorder without specific drug therapy. The aim of the study was to determine the benefits of melatonin for the treatment of delirium in elderly patients with acute heart failure. Patients aged more than 60 years after acute heart failure were included in this research. Patients were randomly chosen to receive either melatonin or placebos randomly by a computer-generated randomization sequence. delirium was the incidence of the disease delirium, which was measured twice daily with the Confusion Assessment Method for the first seven days. A total of 497 patients were randomly selected to receive either placebo or melatonin. In the melatonin group, the incidence of delirium was considerably lower than in the placebo group. Conclusion: According to the new report, acute melatonin therapy may reduce the risk of delirium among elderly acute heart failure patients.

Source link: https://doi.org/10.1532/hsf.4325


Intravenous acetaminophen for postoperative supratentorial craniotomy pain: a prospective, randomized, double-blinded, placebo-controlled trial

OBJECTIVE Acute pain management after cranial surgery is challenging. Patients inadequate pain management post-craniotomy, according to previous studies. After elective craniotomy, the authors present the results of the first prospective study investigating the use of IV acetaminophen in patients. For 48 hours, the experimental group was given 1000 mg/100 ml IV acetaminophen every 8 hours. On the same day, the placebo group received 100 ml of 0. 9% saline. Patient-reported pain scores were released immediately postoperatively and 48 hours after surgery were also recorded. At any time point, no significant differences were found in narcotic consumption between groups. The difference between the treatment and placebo groups was significant. Patients who received postoperative IV acetaminophen after craniotomy did not have significantly reduced narcotic use, but did have markedly lower pain scores after surgery, but did not have significantly reduced pain scores following craniotomy. No. 1 was eligible for clinical trial registration.

Source link: https://doi.org/10.3171/2017.10.jns171464


Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial

OBJECTIVE The growing curiosity in the potential value of biochemical parameters as predictors of injury in severe traumatic brain injury has sparked. METHODS The authors analyzed serum biomarkers in 107 patients with sTBI who were randomized for a placebo-controlled Phase II trial of progesterone with or without hypothermia. An improved binary logistic regression model and receiver operating characteristic curve were used to analyze serum biomarkers for dichotomized Glasgow Outcome Scale score, functional independence measure, and survival status at 6 and 12 months. Survivors with a 1 year experience had significantly elevated Day 7 Pg levels. Nonsurvivors of 1 year had significant GFAP serum levels and Day 7 IL-6 serum tests on day 7 and Day 7. Individual predictors of outcome at 1 year were serum levels of Day 7 Pg; admission IL-6; and Day 7 GFAP; multivariate logistic regression analysis, independent predictors of outcome at 1 year were serum levels of action in multivariate logistic regression study, independent predictors of outcome at 1 year; admission IL-6; and Day 7 GFAP.

Source link: https://doi.org/10.3171/2015.6.jns15674


Randomized, double-blinded, placebo-controlled trial comparing two multimodal opioid-minimizing pain management regimens following transsphenoidal surgery

Following transsphenoidal surgery for pituitary lesions, no studies have looked at postoperative pain control. Following transsphenoidal surgery, 1 review postoperative pain scores, 2 determine if multimodal opioid-minimizing pain regimens resulted in safe postoperative pain management, and 3 determine if intravenous IV ibuprofen improved postoperative pain scores and reduced opioid use relative to placebo. Mean VAS pain scores were significantly different in Group 1 1. 7. 4 2. 8 compared to Group 2 2. 8; p 0. 0001. Opioid use in Group 1 26. 3 mg OME was significantly different from that of Group 2 62. 5 mg OME, with a 58% decrease in Group 1 26. 3 mg OME relative to Group 2 62. 5 u00b1 63. 8 mg OME; p 0. 0001. Compared to placebo, IV ibuprofen resulted in significantly raised pain scores and dramatically reduced opioid use.

Source link: https://doi.org/10.3171/2016.10.jns161355


Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury

Male Wistar adult rats were treated randomly with 0, 0. 8, 2. 5, or 7. 5 ml/kg of Cerebrolysin 4 hours after mTBI caused by a closed head blow for a total of ten days. Cerebrolysin has a significant dose effect on cognitive function 3 months after the injury was discovered. Cerebrolysin at a dose of u2265 0. 8 mg/kg improved cognitive performance. Sensorimotor function at a dose of 2. 5 or 7. 5 ml/kg may have caused differing onset times of significant improvement in sensorimotor function. This preclinical, placebo-controlled, and blinded research with a clinically appropriate treatment program found that Cerebrolysin in doses of 0. 8 ml/kg, administered 4 hours after mTBI and then daily for ten days, improved functional outcomes three months after injury.

Source link: https://doi.org/10.3171/2017.6.jns171007


Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial

Object The authors have previously reported that acute pravastatin therapy in patients after aneurysmal hemorrhage improves vasospasm-related delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. Methods Eighty patients with aneurysmal SAH were enrolled in a double-blind study and randomly assigned to receive 40 mg of oral pravastatin or placebo every day for up to 14 days. On Day 3 compared to those patients who did not vaping, patients with pravastatin but severe vaping had significantly lower baseline LDL cholesterol levels or a less significant decrease in LDL cholesterol reduction, as well as elevated plasma fibrinogen and serum C-reactive protein. The reduction in LDL cholesterol levels on Day 3 in the placebo group was correlated to the period of normal cerebral autoregulation on the ipsilateral side of the ruptured aneurysm. Conclusions: In addition to acting in an cholesterol-independent manner, acute statin therapy following aneurysmal SAH may also function by cholesterol-dependent pathways.

Source link: https://doi.org/10.3171/jns-07/12/1092


A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine

The evidence relating to IV ketamineu2019s specific effects on suicidal ideation is less clear, however. This review, which sought to see if there was a difference between placebo and overall depressive symptoms vs. suicidal urge, could help explain these divergent findings. Suicidal appetite remained higher among people receiving saline placebo therapy than those indexed from traditional depression rating scales, except for anxiety. Greater placebo response was observed for suicidal ideation compared to depressed mood or anhedonia, and no significant differences were found when comparing suicidal ideation with anxiety or guilt. Conclusions: The findings, taken together, reveal preliminary evidence of a contrasting placebo response for suicidal ideation vs. other depressive signs, while anxiety and suicidal ideation have similar placebo response profiles. These findings may help explain the more modest results in clinical IV ketamine trials for suicidal ideation than general depression.

Source link: https://doi.org/10.1093/ijnp/pyac055


Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial

OBJECTIVE IN this review The authors' aim was to identify the differences in the incidence of delayed cerebral ischemia in patients treated with dapsone and those treated with placebo. METHODS A prospective, double-blind, placebo-controlled trial was conducted and included patients with aneurysmal subarachnoid hemorrhage within 5 days of ictus exclusion, but who had a Fisher grade of 3 or 4. DCI on CT was detected in every patient at discharge and 3 months later, and it was 3 months later. To compare quantitative variables, we used the chi-square test to compare the DCI incidence in both groups and the Student t-test or nonparametric tests to compare quantitative variables. In addition, the brain infarction rate in the dapsone group was lower than the dapsone group. After aneurysmal SAH, Dapsone seems to play a prophylactic agent in patients at high risk of experiencing DCI.

Source link: https://doi.org/10.3171/2021.12.focus21663


Preemptive analgesia for postoperative pain relief in thoracolumbosacral spine operations: a double-blind, placebo-controlled randomized trial

OBJECTIVE Preemptive administration of analgesic medication is more effective than opioid therapy following the onset of the traumatic response. The safety of preoperative or preemptive pain relief following thoracolumbosacral spine surgery has not been well investigated. The most significant result was the presence of opioid sparing and rescue time, which was u2014 defined as the time between patient extubation and the time when pain medication was first requested during the postoperative period. CONCLUSIONS The authors' study showed that preemptive analgesia in thoracolumbosacral surgeries could significantly reduce analgesia requirements in the immediate postoperative period, as shown by reduced demand for opioid drugs in both analgesia study groups who received a preoperative analgesia epidural. However, the lack of disparities in pain score and opioid dose at the PACU puts into question the use of preemptive epidural opioids in spine surgery patients.

Source link: https://doi.org/10.3171/2018.5.spine171380

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions